Global mRNA Vaccines & Therapeutics Market Growth (Status and Outlook) 2021-2026

March 2021 | 115 pages | ID: GC4B59126172EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

According to this latest study, the 2021 growth of mRNA Vaccines & Therapeutics will have significant change from previous year. By the most conservative estimates of global mRNA Vaccines & Therapeutics market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2021, from US$ xx million in 2020. Over the next five years the mRNA Vaccines & Therapeutics market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2026.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines & Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.

• Infectious Disease Vaccines
• Cancer Vaccines

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.

• Infectious Disease
• Cancer

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Moderna Therapeutics
• CureVac
• Translate Bio
• BioNTech
• Sangamo Therapeutics
• Argos Therapeutics
• In-Cell-Art
• eTheRNA
• Ethris
• Tiba Biotechnology

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global mRNA Vaccines & Therapeutics Market Size 2016-2026
  2.1.2 mRNA Vaccines & Therapeutics Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 mRNA Vaccines & Therapeutics Segment by Type
  2.2.1 Infectious Disease Vaccines
  2.2.2 Infectious Disease Vaccines
2.3 mRNA Vaccines & Therapeutics Market Size by Type
  2.3.1 Global mRNA Vaccines & Therapeutics Market Size CAGR by Type
  2.3.2 Global mRNA Vaccines & Therapeutics Market Size Market Share by Type (2016-2021)
2.4 mRNA Vaccines & Therapeutics Segment by Application
  2.4.1 Infectious Disease
  2.4.2 Cancer
2.5 mRNA Vaccines & Therapeutics Market Size by Application
  2.5.1 Global mRNA Vaccines & Therapeutics Market Size CAGR by Application
  2.5.2 Global mRNA Vaccines & Therapeutics Market Size Market Share by Application (2016-2021)

3 MRNA VACCINES & THERAPEUTICS MARKET SIZE BY PLAYERS

3.1 mRNA Vaccines & Therapeutics Market Size Market Share by Players
  3.1.1 Global mRNA Vaccines & Therapeutics Revenue by Players (2019-2021E)
  3.1.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Players (2019-2021E)
3.2 Global mRNA Vaccines & Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 MRNA VACCINES & THERAPEUTICS BY REGIONS

4.1 mRNA Vaccines & Therapeutics Market Size by Regions (2016-2021)
4.2 Americas mRNA Vaccines & Therapeutics Market Size Growth (2016-2021)
4.3 APAC mRNA Vaccines & Therapeutics Market Size Growth (2016-2021)
4.4 Europe mRNA Vaccines & Therapeutics Market Size Growth (2016-2021)
4.5 Middle East & Africa mRNA Vaccines & Therapeutics Market Size Growth (2016-2021)

5 AMERICAS

5.1 Americas mRNA Vaccines & Therapeutics Market Size by Country (2016-2021)
5.2 Americas mRNA Vaccines & Therapeutics Market Size by Type (2016-2021)
5.3 Americas mRNA Vaccines & Therapeutics Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC mRNA Vaccines & Therapeutics Market Size by Region (2016-2021)
6.2 APAC mRNA Vaccines & Therapeutics Market Size by Type (2016-2021)
6.3 APAC mRNA Vaccines & Therapeutics Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe mRNA Vaccines & Therapeutics by Country (2016-2021)
7.2 Europe mRNA Vaccines & Therapeutics Market Size by Type (2016-2021)
7.3 Europe mRNA Vaccines & Therapeutics Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Region (2016-2021)
8.2 Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Type (2016-2021)
8.3 Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 GLOBAL MRNA VACCINES & THERAPEUTICS MARKET FORECAST

10.1 Global mRNA Vaccines & Therapeutics Forecast by Regions (2021-2026)
  10.1.1 Global mRNA Vaccines & Therapeutics Forecast by Regions (2021-2026)
  10.1.2 Americas mRNA Vaccines & Therapeutics Forecast
  10.1.3 APAC mRNA Vaccines & Therapeutics Forecast
  10.1.4 Europe mRNA Vaccines & Therapeutics Forecast
  10.1.5 Middle East & Africa mRNA Vaccines & Therapeutics Forecast
10.2 Americas mRNA Vaccines & Therapeutics Forecast by Countries (2021-2026)
  10.2.1 United States mRNA Vaccines & Therapeutics Market Forecast
  10.2.2 Canada mRNA Vaccines & Therapeutics Market Forecast
  10.2.3 Mexico mRNA Vaccines & Therapeutics Market Forecast
  10.2.4 Brazil mRNA Vaccines & Therapeutics Market Forecast
10.3 APAC mRNA Vaccines & Therapeutics Forecast by Region (2021-2026)
  10.3.1 China mRNA Vaccines & Therapeutics Market Forecast
  10.3.2 Japan mRNA Vaccines & Therapeutics Market Forecast
  10.3.3 Korea mRNA Vaccines & Therapeutics Market Forecast
  10.3.4 Southeast Asia mRNA Vaccines & Therapeutics Market Forecast
  10.3.5 India mRNA Vaccines & Therapeutics Market Forecast
  10.3.6 Australia mRNA Vaccines & Therapeutics Market Forecast
10.4 Europe mRNA Vaccines & Therapeutics Forecast by Country (2021-2026)
  10.4.1 Germany mRNA Vaccines & Therapeutics Market Forecast
  10.4.2 France mRNA Vaccines & Therapeutics Market Forecast
  10.4.3 UK mRNA Vaccines & Therapeutics Market Forecast
  10.4.4 Italy mRNA Vaccines & Therapeutics Market Forecast
  10.4.5 Russia mRNA Vaccines & Therapeutics Market Forecast
10.5 Middle East & Africa mRNA Vaccines & Therapeutics Forecast by Region (2021-2026)
  10.5.1 Egypt mRNA Vaccines & Therapeutics Market Forecast
  10.5.2 South Africa mRNA Vaccines & Therapeutics Market Forecast
  10.5.3 Israel mRNA Vaccines & Therapeutics Market Forecast
  10.5.4 Turkey mRNA Vaccines & Therapeutics Market Forecast
  10.5.5 GCC Countries mRNA Vaccines & Therapeutics Market Forecast
10.6 Global mRNA Vaccines & Therapeutics Forecast by Type (2021-2026)
10.8 Global mRNA Vaccines & Therapeutics Forecast by Application (2021-2026)

11 KEY PLAYERS ANALYSIS

11.1 Moderna Therapeutics
  11.1.1 Moderna Therapeutics Company Information
  11.1.2 Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered
  11.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
  11.1.4 Moderna Therapeutics Main Business Overview
  11.1.5 Moderna Therapeutics Latest Developments
11.2 CureVac
  11.2.1 CureVac Company Information
  11.2.2 CureVac mRNA Vaccines & Therapeutics Product Offered
  11.2.3 CureVac mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
  11.2.4 CureVac Main Business Overview
  11.2.5 CureVac Latest Developments
11.3 Translate Bio
  11.3.1 Translate Bio Company Information
  11.3.2 Translate Bio mRNA Vaccines & Therapeutics Product Offered
  11.3.3 Translate Bio mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
  11.3.4 Translate Bio Main Business Overview
  11.3.5 Translate Bio Latest Developments
11.4 BioNTech
  11.4.1 BioNTech Company Information
  11.4.2 BioNTech mRNA Vaccines & Therapeutics Product Offered
  11.4.3 BioNTech mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
  11.4.4 BioNTech Main Business Overview
  11.4.5 BioNTech Latest Developments
11.5 Sangamo Therapeutics
  11.5.1 Sangamo Therapeutics Company Information
  11.5.2 Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered
  11.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
  11.5.4 Sangamo Therapeutics Main Business Overview
  11.5.5 Sangamo Therapeutics Latest Developments
11.6 Argos Therapeutics
  11.6.1 Argos Therapeutics Company Information
  11.6.2 Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered
  11.6.3 Argos Therapeutics mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
  11.6.4 Argos Therapeutics Main Business Overview
  11.6.5 Argos Therapeutics Latest Developments
11.7 In-Cell-Art
  11.7.1 In-Cell-Art Company Information
  11.7.2 In-Cell-Art mRNA Vaccines & Therapeutics Product Offered
  11.7.3 In-Cell-Art mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
  11.7.4 In-Cell-Art Main Business Overview
  11.7.5 In-Cell-Art Latest Developments
11.8 eTheRNA
  11.8.1 eTheRNA Company Information
  11.8.2 eTheRNA mRNA Vaccines & Therapeutics Product Offered
  11.8.3 eTheRNA mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
  11.8.4 eTheRNA Main Business Overview
  11.8.5 eTheRNA Latest Developments
11.9 Ethris
  11.9.1 Ethris Company Information
  11.9.2 Ethris mRNA Vaccines & Therapeutics Product Offered
  11.9.3 Ethris mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
  11.9.4 Ethris Main Business Overview
  11.9.5 Ethris Latest Developments
11.10 Tiba Biotechnology
  11.10.1 Tiba Biotechnology Company Information
  11.10.2 Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered
  11.10.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
  11.10.4 Tiba Biotechnology Main Business Overview
  11.10.5 Tiba Biotechnology Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. mRNA Vaccines & Therapeutics Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Infectious Disease Vaccines
Table 3. Major Players of Cancer Vaccines
Table 4. mRNA Vaccines & Therapeutics Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 5. Global mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 6. Global mRNA Vaccines & Therapeutics Market Size Market Share by Type (2016-2021)
Table 7. mRNA Vaccines & Therapeutics Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 8. Global mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 9. Global mRNA Vaccines & Therapeutics Market Size Market Share by Application (2016-2021)
Table 10. Global mRNA Vaccines & Therapeutics Revenue by Players (2019-2021E) & ($ Millions)
Table 11. Global mRNA Vaccines & Therapeutics Revenue Market Share by Players (2019-2021E)
Table 12. mRNA Vaccines & Therapeutics Key Players Head office and Products Offered
Table 13. mRNA Vaccines & Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global mRNA Vaccines & Therapeutics Market Size by Regions 2016-2021 & ($ Millions)
Table 17. Global mRNA Vaccines & Therapeutics Market Size Market Share by Regions 2016-2021
Table 18. Americas mRNA Vaccines & Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 19. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Country (2016-2021)
Table 20. Americas mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 21. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Type (2016-2021)
Table 22. Americas mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 23. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Application (2016-2021)
Table 24. APAC mRNA Vaccines & Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 25. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Region (2016-2021)
Table 26. APAC mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 27. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Type (2016-2021)
Table 28. APAC mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 29. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Application (2016-2021)
Table 30. Europe mRNA Vaccines & Therapeutics Market Size by Country (2016-2021) & ($ Millions)
Table 31. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Country (2016-2021)
Table 32. Europe mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 33. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Type (2016-2021)
Table 34. Europe mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 35. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Application (2016-2021)
Table 36. Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Region (2016-2021) & ($ Millions)
Table 37. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Region (2016-2021)
Table 38. Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Type (2016-2021) & ($ Millions)
Table 39. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Type (2016-2021)
Table 40. Middle East & Africa mRNA Vaccines & Therapeutics Market Size by Application (2016-2021) & ($ Millions)
Table 41. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Application (2016-2021)
Table 42. Key and Potential Regions of mRNA Vaccines & Therapeutics
Table 43. Key Application and Potential Industries of mRNA Vaccines & Therapeutics
Table 44. Key Challenges of mRNA Vaccines & Therapeutics
Table 45. Key Trends of mRNA Vaccines & Therapeutics
Table 46. Global mRNA Vaccines & Therapeutics Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 47. Global mRNA Vaccines & Therapeutics Market Size Market Share Forecast by Regions (2021-2026)
Table 48. Global mRNA Vaccines & Therapeutics Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 49. Global mRNA Vaccines & Therapeutics Market Size Market Share Forecast by Type (2021-2026)
Table 50. Global mRNA Vaccines & Therapeutics Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 51. Global mRNA Vaccines & Therapeutics Market Size Market Share Forecast by Application (2021-2026)
Table 52. Moderna Therapeutics Details, Company Type, mRNA Vaccines & Therapeutics Area Served and Its Competitors
Table 53. Moderna Therapeutics mRNA Vaccines & Therapeutics Product Offered
Table 54. Moderna Therapeutics mRNA Vaccines & Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 55. Moderna Therapeutics Main Business
Table 56. Moderna Therapeutics Latest Developments
Table 57. CureVac Details, Company Type, mRNA Vaccines & Therapeutics Area Served and Its Competitors
Table 58. CureVac mRNA Vaccines & Therapeutics Product Offered
Table 59. CureVac Main Business
Table 60. CureVac mRNA Vaccines & Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 61. CureVac Latest Developments
Table 62. Translate Bio Details, Company Type, mRNA Vaccines & Therapeutics Area Served and Its Competitors
Table 63. Translate Bio mRNA Vaccines & Therapeutics Product Offered
Table 64. Translate Bio Main Business
Table 65. Translate Bio mRNA Vaccines & Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 66. Translate Bio Latest Developments
Table 67. BioNTech Details, Company Type, mRNA Vaccines & Therapeutics Area Served and Its Competitors
Table 68. BioNTech mRNA Vaccines & Therapeutics Product Offered
Table 69. BioNTech Main Business
Table 70. BioNTech mRNA Vaccines & Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 71. BioNTech Latest Developments
Table 72. Sangamo Therapeutics Details, Company Type, mRNA Vaccines & Therapeutics Area Served and Its Competitors
Table 73. Sangamo Therapeutics mRNA Vaccines & Therapeutics Product Offered
Table 74. Sangamo Therapeutics Main Business
Table 75. Sangamo Therapeutics mRNA Vaccines & Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 76. Sangamo Therapeutics Latest Developments
Table 77. Argos Therapeutics Details, Company Type, mRNA Vaccines & Therapeutics Area Served and Its Competitors
Table 78. Argos Therapeutics mRNA Vaccines & Therapeutics Product Offered
Table 79. Argos Therapeutics Main Business
Table 80. Argos Therapeutics mRNA Vaccines & Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 81. Argos Therapeutics Latest Developments
Table 82. In-Cell-Art Details, Company Type, mRNA Vaccines & Therapeutics Area Served and Its Competitors
Table 83. In-Cell-Art mRNA Vaccines & Therapeutics Product Offered
Table 84. In-Cell-Art Main Business
Table 85. In-Cell-Art mRNA Vaccines & Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 86. In-Cell-Art Latest Developments
Table 87. eTheRNA Details, Company Type, mRNA Vaccines & Therapeutics Area Served and Its Competitors
Table 88. eTheRNA mRNA Vaccines & Therapeutics Product Offered
Table 89. eTheRNA Main Business
Table 90. eTheRNA mRNA Vaccines & Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 91. eTheRNA Latest Developments
Table 92. Ethris Details, Company Type, mRNA Vaccines & Therapeutics Area Served and Its Competitors
Table 93. Ethris mRNA Vaccines & Therapeutics Product Offered
Table 94. Ethris Main Business
Table 95. Ethris mRNA Vaccines & Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 96. Ethris Latest Developments
Table 97. Tiba Biotechnology Details, Company Type, mRNA Vaccines & Therapeutics Area Served and Its Competitors
Table 98. Tiba Biotechnology mRNA Vaccines & Therapeutics Product Offered
Table 99. Tiba Biotechnology Main Business
Table 100. Tiba Biotechnology mRNA Vaccines & Therapeutics Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 101. Tiba Biotechnology Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. mRNA Vaccines & Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global mRNA Vaccines & Therapeutics Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global mRNA Vaccines & Therapeutics Market Size Market Share by Type in 2020
Figure 7. mRNA Vaccines & Therapeutics in Infectious Disease
Figure 8. Global mRNA Vaccines & Therapeutics Market: Infectious Disease (2016-2021) & ($ Millions)
Figure 9. mRNA Vaccines & Therapeutics in Cancer
Figure 10. Global mRNA Vaccines & Therapeutics Market: Cancer (2016-2021) & ($ Millions)
Figure 11. Global mRNA Vaccines & Therapeutics Market Size Market Share by Application in 2020
Figure 12. Global mRNA Vaccines & Therapeutics Revenue Market Share by Player in 2020
Figure 13. Global mRNA Vaccines & Therapeutics Market Size Market Share by Regions (2016-2021)
Figure 14. Americas mRNA Vaccines & Therapeutics Market Size 2016-2021 ($ Millions)
Figure 15. APAC mRNA Vaccines & Therapeutics Market Size 2016-2021 ($ Millions)
Figure 16. Europe mRNA Vaccines & Therapeutics Market Size 2016-2021 ($ Millions)
Figure 17. Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2016-2021 ($ Millions)
Figure 18. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Country in 2020
Figure 19. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Type in 2020
Figure 20. Americas mRNA Vaccines & Therapeutics Market Size Market Share by Application in 2020
Figure 21. United States mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 22. Canada mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 23. Mexico mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 24. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Regions in 2020
Figure 25. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Type in 2020
Figure 26. APAC mRNA Vaccines & Therapeutics Market Size Market Share by Application in 2020
Figure 27. China mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 28. Japan mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 29. Korea mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 30. Southeast Asia mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 31. India mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 32. Australia mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 33. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Country in 2020
Figure 34. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Type in 2020
Figure 35. Europe mRNA Vaccines & Therapeutics Market Size Market Share by Application in 2020
Figure 36. Germany mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 37. France mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 38. UK mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 39. Italy mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 40. Russia mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 41. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Region in 2020
Figure 42. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Type in 2020
Figure 43. Middle East & Africa mRNA Vaccines & Therapeutics Market Size Market Share by Application in 2020
Figure 44. Egypt mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 45. South Africa mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 46. Israel mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 47. Turkey mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 48. GCC Country mRNA Vaccines & Therapeutics Market Size Growth 2016-2021 ($ Millions)
Figure 49. Americas mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 50. APAC mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 51. Europe mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 52. Middle East & Africa mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 53. United States mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 54. Canada mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 55. Mexico mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 56. Brazil mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 57. China mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 58. Japan mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 59. Korea mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 60. Southeast Asia mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 61. India mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 62. Australia mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 63. Germany mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 64. France mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 65. UK mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 66. Italy mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 67. Russia mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 68. Spain mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 69. Egypt mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 70. South Africa mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 71. Israel mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 72. Turkey mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)
Figure 73. GCC Country mRNA Vaccines & Therapeutics Market Size 2021-2026 ($ Millions)